Sec Form 4 Filing - WAREHAM JOHN P @ RESMED INC - 2012-08-06

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person WAREHAM JOHN P 2. Issuer Name and Ticker or Trading Symbol RESMED INC [ RMD] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) RESMED INC., 9001 SPECTRUM CENTER BLVD. 3. Date of Earliest Transaction (MM/DD/YY) 08/06/2012 (Street) SAN DIEGO, CA92123 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price ResMed Common Stock 08/06/2012 M 12,000 A $ 23.095 22,000 D ResMed Common Stock 08/06/2012 S 12,000 D $ 35.7354 10,000 D ResMed Common Stock 08/07/2012 M 5,942 A $ 21.025 15,942 D ResMed Common Stock 08/07/2012 S 5,942 D $ 35.8 10,000 D ResMed Common Stock 08/07/2012 M 9,058 A $ 21.025 19,058 D ResMed Common Stock 08/07/2012 S 9,058 D $ 36.12 10,000 D ResMed Common Stock 08/07/2012 M 3,000 A $ 21.025 13,000 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares ResMed NQ Stock Options $ 23.095 08/06/2012 M 12,000 11/10/2007( 1 ) 11/10/2013 ResMed Common Stock 12,000 $ 0 0 D ResMed NQ Stock Options $ 21.025 08/07/2012 M 5,942 11/07/2008( 1 ) 11/07/2014 ResMed Common Stock 5,942 $ 0 30,058 D ResMed NQ Stock Options $ 21.025 08/07/2012 M 9,058 11/07/2008( 1 ) 11/07/2014 ResMed Common Stock 9,058 $ 0 21,000 D ResMed NQ Stock Options $ 21.025 08/07/2012 M 3,000 11/07/2008( 1 ) 11/07/2014 ResMed Common Stock 3,000 $ 0 18,000 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other WAREHAM JOHN P RESMED INC. 9001 SPECTRUM CENTER BLVD. SAN DIEGO, CA92123 X Signatures John P. Wareham 08/08/2012 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Represents date options first became exercisable.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.